TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details

Profile for Ron Hall II, PharmD, MSCS

Ronald Hall

Ron Hall II, PharmD, MSCS

  • Associate Professor
Office Phone: 214-654-9404 ext 231
Mail Address: 5920 Forest Park Rd Ste 400
Dallas TX 75235-6418


Dr. Hall serves as the program director for the Dose Optimization and Outcomes Research (DOOR) progam. The DOOR program focuses on providing evidence to optimize the dosing and outcomes of medications for obese patients. Dr. Hall was selected as a National Institutes of Health Clinical Research Scholar in 2006. He was also the recipient of the 2008 Young Alumni Award from the St. Louis College of Pharmacy.

Research Interests

obesity, pharmacokinetics, antimicrobial, cancer, outcomes research

Selected Publications:

  • Hall RG, Swancutt MA, Meek CC, Leff RD, Gumbo T. Weight drives caspofungin variability in overweight and obese people: fractal power signatures beyond 2/3 or 3/4. Antimicrob Agents Chemother. 2013;57(5):2259-64.
  • Hall RG, Hazlewood KA, Brouse SD, Giuliano CA, Haase KK, Frei CR, Forcade NA, Bell TE, Bedimo RJ, Alvarez CA. Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. BMC Pharmacology & Toxiciology. 2013;14:12.
  • Pasipanodya J, Hall RG, Gumbo T. Tuberculosis and Other Mycobacterial Diseases. Elsevier Inc.. 2012.
  • Hall RG, Giuliano CA, Haase KK, Hazlewood KA, Frei CR, Forcade NA, Brouse SD, Bell TE, Bedimo RJ, Alvarez CA. Empiric Guideline-Recommended Weight-Based Vancomycin Dosing and Mortality in Mathicillin-Resistant Staphylococcus aureus Bacteremia: A Retrospective Cohort Study. BMC Infectious DIseases. 2012;12:104.
  • Hall RG, Swancutt M, Meek CC, Leff RD, Gumbo T. Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people. Antimicrob Agents Chemother. 2012;56(3):1502-1507.